In yesterday’s Wall Street session, Seelos Therapeutics Inc (NASDAQ:SEEL) shares traded at $0.34, up 13.11% from the previous session.
SEEL stock price is now 6.76% away from the 50-day moving average and -92.07% away from the 200-day moving average. The market capitalization of the company currently stands at $2.36M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $2.50 to $8, ROTH Capital Upgraded its rating from Neutral to Buy for Seelos Therapeutics Inc (NASDAQ: SEEL). On July 01, 2021, Guggenheim recently initiated its ‘Buy’ rating on the stock quoting a target price of $8, while ‘Cantor Fitzgerald’ rates the stock as ‘Overweight’
In other news, Golembiewski Michael Joseph, Chief Financial Officer bought 83,000 shares of the company’s stock on Nov 30 ’23. The stock was bought for $100,222 at an average price of $1.21. Upon completion of the transaction, the Chief Financial Officer now directly owns 86,450 shares in the company, valued at $29393.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 01 ’23, Mehra Raj bought 75,757 shares of the business’s stock. A total of $99,999 was incurred on buying the stock at an average price of $1.32. This leaves the insider owning 185,142 shares of the company worth $62948.28. A total of 1.43% of the company’s stock is owned by insiders.
During the past 12 months, Seelos Therapeutics Inc has had a low of $0.18 and a high of $53.04. The fifty day moving average price for SEEL is $0.307504 and a two-hundred day moving average price translates $3.8975246 for the stock.
The latest earnings results from Seelos Therapeutics Inc (NASDAQ: SEEL) was released for 2024-06-30. The company reported revenue of $0.38 million for the quarter, compared to $0.34 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 11.9 percent.
